Sculptra™
Sculptra™ is a sculpting agent that restores volume to correct the signs of facial fat loss. Sculptra™ was approved by the FDA in August 2004 tospecifically treat HIV lipoatrophy of the face, the “sunken cheek” syndrome which often stigmatizes persons with HIV disease.What is Sculptra™?
Polylactic acid is the main ingredient in Sculptra™, created by a French chemist in 1954 the acid is of artificial origin so no animal sensitivity is involved. The acid is also biodegradable, biocompatible, and immunologically inert. Sculptra™ has been widely used for many years in dissolvable stitches, bone screws and facial implants.
How does it work?
Sculptra™ works by temporarily adding volume to facial tissue and restoring a smoother, fuller appearance to the face. After the initial treatment series, repeat treatments may be needed to maintain the effect.
When is it used?
Sculptra™ is injected by a doctor into areas of facial fat loss (facial lipoatrophy) in patients with, or receiving treatment for, Human Immunodeficiency Virus (HIV).
What will it accomplish?
Sculptra™will restore shape and contour deficiencies in areas of facial lipoatrophy. The implant temporarily adds volume to the face and can give the appearance of a smoother, fuller face.
How long will it last?
How long Sculptra™ will last is unpredictable, but a rough estimate is 18 months; however, no patient treated in the study ever went back to “ground zero.”
